Average Co-Inventor Count = 4.18
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ocera Therapeutics, Inc. (8 from 26 patents)
2. Mcgill University (7 from 274 patents)
3. Tranzyme Pharma Inc. (3 from 19 patents)
4. Socpra Sciences Sante Et Humaines S.e.c. (3 from 10 patents)
5. Socpra Sciences Et Genie S.e.c. (2 from 48 patents)
6. Isis Pharmaceuticals, Inc. (1 from 1,035 patents)
7. Sanofi-synthelabo (1 from 152 patents)
24 patents:
1. 10258602 - Macrocyclic ghrelin receptor modulators and methods of using the same
2. 10208308 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections
3. 10040751 - Intermediates for macrocyclic compounds
4. 9993491 - Guanine riboswitch binding compounds and their use as antibiotics
5. 9949949 - Macrocyclic ghrelin receptor modulators and methods of using the same
6. 9752149 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections
7. 9493505 - Macrocyclic modulators of the ghrelin receptor
8. 9457033 - Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
9. 9371297 - Macrocyclic ghrelin receptor modulators and methods of using the same
10. 9365853 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections
11. 9181298 - Intermediates for macrocyclic compounds
12. 9133235 - Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
13. 8921521 - Macrocyclic modulators of the Ghrelin receptor
14. 8334256 - Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor
15. 8129561 - Processes for intermediates for macrocyclic compounds